EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of enterolactone with blood pressure and hypertension risk in NHANES

Cynthia M Weiner iD, Shannon E Khan, Caleb Leong, Sushant M Ranadive, Sara C Campbell, Jeffrey T Howard, Kevin S Heffernan iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0302254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Cynthia M Weiner und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology, University of Maryland, College Park, Maryland, United States of America. Hauptthemen laut MEDLINE: Hypertension, Blood Pressure, 4-Butyrolactone, Lignans. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome may affect overall cardiometabolic health. Enterolactone is an enterolignan reflective of dietary lignan intake and gut microbiota composition and diversity that can be measured in the urine. The purpose of this study was to examine the association between urinary enterolactone concentration as a reflection of gut health and blood pressure/risk of hypertension in a large representative sample from the US population. This analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) collected from January 1999 through December 2010. Variables of interest included participant characteristics (including demographic, anthropometric and social/environmental factors), resting blood pressure and hypertension history, and urinary enterolactone concentration. 10,637 participants (45 years (SE = 0.3), 51.7% (SE = 0.6%) were female) were included in analyses. In multivariable models adjusted for demographic, socioeconomic and behavioral/environmental covariates, each one-unit change in log-transformed increase in enterolactone was associated with a 0.738 point (95% CI: -0.946, -0.529; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionBlood Pressure4-ButyrolactoneLignansNutrition SurveysHumansFemaleMaleMiddle AgedGastrointestinal MicrobiomeAdultRisk FactorsUnited States

Substanzen

4-ButyrolactoneLignans

Autor:innen und Institutionen

  • Department of Kinesiology, University of Maryland, College Park, Maryland, United States of America.
  • Department of Public Health, University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas, United States of America.
  • Department of Kinesiology and Health, Rutgers University, New Brunswick, New Jersey, United States of America.
  • Department of Exercise Science, Syracuse University, Syracuse, NY, United States of America.

ORCID-Profile: Cynthia M Weiner, Kevin S Heffernan

Zitieren

APA

Weiner, C. M., Khan, S. E., Leong, C., Ranadive, S. M., Campbell, S. C., Howard, J. T., & Heffernan, K. S. (2024). Association of enterolactone with blood pressure and hypertension risk in NHANES. PLOS ONE. https://doi.org/10.1371/journal.pone.0302254

Vancouver

Weiner CM, Khan SE, Leong C, Ranadive SM, Campbell SC, Howard JT, et al. Association of enterolactone with blood pressure and hypertension risk in NHANES. PLOS ONE. 2024. doi:10.1371/journal.pone.0302254

BibTeX
@article{Weiner2024,
  author = {Weiner, Cynthia M and Khan, Shannon E and Leong, Caleb and Ranadive, Sushant M and Campbell, Sara C and Howard, Jeffrey T and Heffernan, Kevin S},
  title = {Association of enterolactone with blood pressure and hypertension risk in NHANES},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0302254}
}
Kostenlos starten →